Soren Klim, Stig Mortensen and Henrik Madsen
Deconvolution of Insulin Secretion Rates
|
M. Andrew (1), M. Li (2), D. Salinger (1), P. Vicini (1), J. Wang (2), R. Grady (3), B. Phillips (4), D. Shen (1,2,4), G. Anderson (2,5)
Effect of Cranberry Juice on Population Pharmacokinetics of Amoxicillin and Cefaclor
|
M.A.Barras(1,2), S.B.Duffull(3), J.J.Atherton(4), B Green(1)
Individualized compared with conventional dosing of enoxaparin.
|
Inès Paule (1), Michel Tod (1), Emilie Hénin (1), Benoit You (1), Brigitte Tranchand (1), Gilles Freyer (1,2), Pascal Girard (1)
Model-based dose adaptation of capecitabine for prevention of severe hand-and-foot syndrome: in silico comparison with the standard method
|
Jeffrey S Barrett1, Robin Norris1, Sundararajan Vijayakumar2, John Mondick1, Kalpana Vijayakumar2, Bhuvana Jayaraman1, Erin Cummins1, Mahesh Narayan1, Athena Zuppa1, Jeffrey M. Skolnik1
Enhancing Methotrexate Pharmacotherapy in Children with Cancer: A Decision Support System Integrating Real-time PK/PD Modeling and Simulation with Patient Medical Records
|
PP Tanos(1), SB Duffull(1,2), CMJ Kirkpatrick(1), DG Lalloo(3), GK Isbister (4)
A system model for the clotting cascade challenges clinical management of snake bites.
|
Lena E. Friberg* (1), Rik de Greef (2), Thomas Kerbusch (2), Mats O. Karlsson (1)
Modeling and Simulation of the Asenapine Exposure-Response and Drop-Out in Acute Schizophrenia
|
L. Claret(1), F. Schaedeli Stark(2), F. Sirzen(2), R. Gieschke(2), R. Bruno(1)
A modeling framework to simulate Xeloda dose intensity and survival in colorectal cancer
|
JF Standing (1), EG Greening (2), V Holden (2), S Picton (2), N Young (2), H Chrystyn (3), MO Karlsson (1).
Predicting Paediatric Tobramycin Pharmacokinetics with Five Different Methods
|
Alwin D.R. Huitema
Application of modelling and simulation in clinical oncology
|
Joga Gobburu
How Disease Models can reduce late phase attrition rate to half by 2015
|
